Hepatitis C virus infection rates and risk factors in an Australian hospital endoscopy cohort

Australian and New Zealand Journal of Public Health

Volumn 33, Issue 5, 2009, Pages 442-448

  Vickery, Karen ^a   Tawk, Hani M ^b   Bisset, Linda ^b   Selby, Warwick ^c   Cossart, Yvonne E ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Australia; Endoscopy; Hepatitis C infection; Prevalence; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR; GROWTH HORMONE; HEPATITIS C ANTIBODY;

ACUPUNCTURE; ADULT; ARTICLE; AUSTRALIA; BLOOD TRANSFUSION; COHORT ANALYSIS; DRUG USE; ENDOSCOPY; FEMALE; HEPATITIS C; HOSPITAL PATIENT; HUMAN; IMMIGRANT; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TATTOOING; BLOOD; HEALTH SURVEY; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; TRANSMISSION;

AUSTRALIA; COHORT STUDIES; ENDOSCOPY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 70350322478     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2009.00426.x     Document Type: Article

References (12)

1. World Health Organisation. Hepatitis C- global prevalence. Wkly Epidemiol Rec. 1999;49:425-427
2. Maio G, D'Argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, et al. Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol. 2000;33:116-120 (Pubitemid 30418942)
3. Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H. Epidemiology of hepatitis C virus in Japan. Intervirology. 2004;42(2-3):153-158
4. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20:1-16. (Pubitemid 30421405)
5. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, et al. Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Nat Acad Sci U S A. 2002;99(24):15584-15589 (Pubitemid 35403976)
6. Amin J, Gidding H, Gilbert G, Backhouse J, Kaldor J, Dore G, et al. Hepatitis C prevalence - a nationwide serosurvey. Commun Dis Intell. 2004;28:517-521
7. Tawk HM, Vickery K, Bisset L, Lo SK, Selby W, Cossart YE and the Infection in Endoscopy study group. The current pattern of hepatitis B infection in Australia. J Viral Hepat. 2006;13:206-215
8. Wicker S, Cinatl J, Berger A, Doerr HW, Gottschalk R, Rabenau HF. Determination of risk of infection with blood-borne pathogens following a needlestick injury in hospital workers. Ann Occup Hyg. 2008;52(7):615-622
9. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis. 2005;9(3):383-398
10. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 1998;352(9138):1426-1432 (Pubitemid 28510876)
11. Merkinaite S, Lazarus JV, Gore C. Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Public Health. 2008;16(3):106-110
12. Ostapowicz G, Dallinger M, Bell SJ, Strasser SI, Watson KJ, Slavin J, et al. Changes in hepatitis C-related liver disease in a large clinic population. Intern Med J 2001;31(2):90-96 (Pubitemid 32398075)